Comprehensive Management Of Cardiovascular Risk Factors For Adults With Type 2 Diabetes A Scientific Statement From The American Heart Association

This American Heart Association scientific statement provides updated guidance on protecting heart health in adults with type 2 diabetes, who face significantly higher risks of cardiovascular disease. The researchers reviewed recent evidence showing how managing multiple risk factors together—rather than focusing solely on blood sugar—can dramatically reduce heart-related complications and death in diabetic patients.

The most significant finding involves newer diabetes medications called antihyperglycemic agents, which not only help control blood sugar but also directly protect the heart. Large clinical trials have demonstrated these medications can reduce cardiovascular death, heart attacks, strokes, and heart failure—benefits that go beyond their glucose-lowering effects. The statement also emphasizes the critical importance of blood pressure control and newer cholesterol-lowering therapies as essential components of comprehensive care.

Beyond medications, the research reinforces that lifestyle interventions remain foundational for preventing and managing both diabetes and heart disease. This includes addressing obesity and metabolic syndrome through diet, exercise, and when appropriate, surgical interventions. The authors also highlight how social factors—such as access to healthcare, education, and economic resources—significantly impact a person's ability to manage these conditions effectively.

For patients with diabetes or prediabetes, this research underscores that optimal metabolic health requires a multi-faceted approach. Rather than viewing diabetes management as just blood sugar control, this evidence supports working with healthcare providers to address cardiovascular risk comprehensively through coordinated medication management, lifestyle optimization, and addressing social barriers to care.